Ceftazidime-avibactam use for the treatment of OXA-48- and/or New Delhi metallo-β-lactamase–producing Enterobacterales in cancer patients: a retrospective observational study

Ceftazidime-avibactam use for the treatment of OXA-48- and/or New Delhi metallo-β-lactamase–producing Enterobacterales in cancer patients: a retrospective observational study

BACKGROUND: Infection is the second-leading cause of death among cancer patients, but there have been few studies on the effectiveness of novel antimicrobial agents to treat carbapenem-resistant Enterobacterales in cancer patients. OBJECTIVE: Evaluate the mortality and clinical outcomes of ceftazi-d...

Full description

Bibliographic Details
Main Authors: Ahlam Alghamdi, Hajar AlQahtani, Sara Albilal, Maram Mater Almutairi, Nouf Alobaidallah, Linah Alghamdi, Amal Alfayez, Thamer Almangour, Ahmed Al-jedai
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2023-11-01
Series:Annals of Saudi Medicine
Online Access:http://www.annsaudimed.net/doi/10.5144/0256-4947.2023.373

Internet

http://www.annsaudimed.net/doi/10.5144/0256-4947.2023.373

Similar Items